A study of a new breast cancer treatment, raloxifene, has found that though the drug is effective in preventing breast cancer, it raises the chances of stroke and blood clots in women with cardiovascular risks like hypertension and high cholesterol. In response to the study's results, some researchers say that the cancer-prevention potential of the drug does not justify its increased cardiovascular risk.
Read moreFor years, women who were at high-risk for developing invasive breast cancer, or already had the disease and were trying to prevent a... Read more »
The average lifespan of the American woman continues to rise well past 80 years. Assuming a healthy heart and no other major medical... Read more »
Every doctor has patients that he or she has treated over a lifetime that can be recalled to memory. Often, it is because the circumstances... Read more »
The vast majority of women diagnosed with breast cancer are older; only 5% of breast cancer cases occur in women under age 40, while fully... Read more »
Q. I was diagnosed with ER-receptive breast cancer and have had a lumpectomy and radiation. Now my oncologist has prescribed tamoxifen. I... Read more »
The breast cancer medication Arimidex beats tamoxifen when it comes to preventing recurrences of hormone-receptor-positive breast cancer in... Read more »
My technician recently told me, just before sending me gliding through an MRI tube, that MRI scans were once an uncommon breast exam. He performed... Read more »
Q. I’ve been diagnosed with inflammatory breast cancer. What can you tell me about it, and what my treatment might be like?A. Inflammatory breast... Read more »
Canadian researchers have found that women who take the antidepressant Paxil along with the breast cancer drug tamoxifen may be lowering their chance... Read more »
A new study has found that letrozole (Femara) increases survival more than tamoxifen for postmenopausal women who have undergone surgery. In the... Read more »